Polymer Capital Management (Us) LLC Incyte Corp Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Incyte Corp stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 10,221 shares of INCY stock, worth $647,091. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,221
Previous 4,798
113.03%
Holding current value
$647,091
Previous $331 Million
86.75%
% of portfolio
0.16%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
193MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.95 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.35 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.27 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$941 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$635 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.1B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...